Add
ANX to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| ANX > SEC Filings for ANX > Form 8-K on 4-Aug-2009 | All Recent SEC Filings |
4-Aug-2009
Other Events, Financial Statements and Exhibits
On August 4, 2009, ADVENTRX Pharmaceuticals, Inc. issued a press release announcing that it intends to submit an NDA for ANX-530 (vinorelbine emulsion) around the end of 2009 and that it successfully completed the final manufacturing activities related to the submission, which activities were re-started following its June 2009 equity financing. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
(d) Exhibits.
The list of exhibits called for by this Item is incorporated by reference to the Exhibit Index filed with this report.
|
|